Abstract:BACKGROUND This study aimed to determine whether patterns of tumor clonal origin in pluri-nodular hepatocellular carcinoma (PNHC) could serve as an indicator of tumor recurrence following liver transplantation. MATERIAL AND METHODS Tumor tissue samples from 60 PNHC patients who underwent liver transplantation were examined. The diagnosis of patients conformed to the University of California San Francisco (UCSF) standards for pluri-nodular hepatocellular carcinoma. We performed loss of heterozygosity tests at multiple microsatellite sites to determine the clonal origins of the tumors. Clinical information, pathological data, preoperative serum alpha-feto protein (AFP) and postoperative follow-ups were obtained and correlations between the clonal origin of the tumor, tumor-free survival, pathological characteristics, and AFP levels in serum were studied. RESULTS A total of 165 tumor nodules were collected. Tumor clonal origins were identified as intrahepatic metastasis (IM; 41.67%), multicentric occurrence (MO; 55%) or unidentified (3.33%). Three-year tumor-free survival for the IM group was 48% compared to 75.76% in the MO group (p<0.05), while the occurrence of microscopic tumor thrombus was 100% and 3.03% (p<0.05) for these groups, respectively. The degree of tumor differentiation was 80% for the IM group and 18.18% for the MO group (p<0.05), while the mean AFP concentration for these groups was 226.80 μg/L (2.78-3000 μg/L) and 24.59 μg/L (1.16-531. 30 μg/L; p<0.05), respectively. CONCLUSIONS Clonal origin patterns can serve as important indicators to predict the recurrence of PNHC following liver transplantation. Taken together with pathological characteristics and preoperative serum AFP levels, the risk of recurrence can be established in advance.

The Association of Frequent Allelic Loss on 17p13.1 with Early Metastastic Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Clonal Origin of Hepatocellular Carcinoma and Recurrence after Liver Transplantation

The Roles of Loss of Heterozygosity at 8p22 in the Molecular Classification of Patients with Hepatocellular Carcinoma, with Special Reference to Survival after Surgical Operation

Ioss of Heterozygosity on Chromosomes 8 and 16 in Primary Hepatocellular Carcinoma

[Analysis on Loss of Heterozygosity of Chromosome 17p13.3 in Hepatocellular Carcinoma and Construction of Genomic Contig in the Deleted Region].

[Loss of Heterozygosity of Plasma Circulating DNA from Hepatocellular Carcinoma Patients and Its Clinical Significance].

Loss of Heterozygosity Analysis on Chromosome 8p in Hepatocellular Carcinoma Based on Laser Capture Microdissection

Loss of Heterozygosity at D8S298 is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma

Deletion of Chromosomes 9p and 17 Associated with Abnormal Expression of P53, P16/Mts1 and P15/Mts2 Gene Protein in Hepatocellular Carcinomas

The prognostic value of chromosomal loss of heterozygosity in molecular staging for TNM stage Ⅰ of hepatocellular carcinoma

Study on Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma

Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis

Allelic Imbalance Regions on Chromosomes 8p, 17p and 19p Related to Metastasis of Hepatocellular Carcinoma: Comparison Between Matched Primary and Metastatic Lesions in 22 Patients by Genome-Wide Microsatellite Analysis

The value of chromosomal loss of heterozygosity in prognosis prediction of hepatocellular carcinoma patients with curative resection

Loss of Heterozygosity on Chromosome 10Q22-10Q23 and 22q 11.2- 22q 12.1 and P53 Gene in Primary Hepatocellular Carcinoma

Genetic Aberration in Primary Hepatocellular Carcinoma: Correlation Between P53 Gene Mutation and Loss-of-hetero- Zygosity on Chromosome 16Q21-Q23 and 9P21-P23

Study on Genetic Alterations in Chromosomes 8p and 16q in Primary Hepatocellular Carcinoma

Relation of HCC to Loss of Heterozygosity

Detection and significance of loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas

Microsatellite Alterations on Chromosome 8 of Hepatocellular Carcinoma

Loss of heterozygosity at chromosomal 1p36 in small hepatocellular carcinoma patients